Hemab Therapeutics Holdings, Inc.
COAG · XNASCIK 2114044fmd_1TDYZA92XMGQ772BWA6EBF6S18Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2025 to Sep 30, 2026, 6 periods
0 filings
From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).
Loading